CELLeBRAIN
PrivateLast Round
Series B
Dec 1, 2024
Est. Valuation
$21.16M
Total Funding Raised
$8.83M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CELLeBRAIN is a biotechnology company that develops stem cell-based gene therapies for the treatment of cancers and chronic degenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CELLeBRAIN Comparables
Compare CELLeBRAIN with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iXgene Inc. | 78% | |
| SCM Lifescience | 63% | |
| ENCell Co., Ltd. | 61% | |
CELLeBRAIN Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 1, 2024 | ||||
| Series A | Dec 1, 2021 | ||||
| Corporate Funding | Feb 1, 2021 | ||||
| Pre Seed | Oct 1, 2019 |
CELLeBRAIN Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Laguna Investment | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Monthly visitors increased 31% MoM.
- Apr 8, 2026
Monthly visitors grew 232% MoM, reaching 2.5K.
CELLeBRAIN Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CELLeBRAIN's valuation, stock price, and market status.